Study to Assess Platelet Dysfunction With Verify Now Assay

NYU Langone Health79 enrolled

Overview

The purpose of this study is to conduct a Verify now assay to detect platelet aggregation defects in patients with Myelodysplastic syndrome(MDS), immune thrombocytopenia purpura (ITP) and myeloproliferative disorders (MPD).

Verify Now is a rapid, simple, point-of service assay to measure platelet aggregation. The verify now assay is designed to assess platelet function based on the ability of activated platelets to bind fibrinogen. It is hoped that this study will detect the subtle platelet functional abnormalities in patients with hematological disorders.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Platelet Aggregation Defects

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria \- Patients with common blood disorders such as immune thrombocytopenia purpura(ITP) myelodysplastic syndrome MDS)and myeloproliferative disorders (MPV) Exclusion Criteria \- Patients with normal platelet counts

Locations (1)

Winthrop University Hospital Oncology/Hematology Division

Mineola, New York, United States

Outcomes

Primary Outcomes

platelet aggregation defects

to assess platelet aggregation defects

Time frame: one year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.